AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06414707 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pantoprazole 40mg, Amoxicillin and Levofloxacin
Description: Group (2) included 160 patients received Pantoprazole 40 mg oral twice daily + Levofloxacin 500 mg oral once daily + Amoxicillin 1 gm oral twice daily for 14 days.
Study NCT05179382 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control protocol
Description: I.10 minutes of initial rest in the supine position; II. 90 minutes of treadmill aerobic exercise at an intensity of 60% of the vo2 peak; IV. 60 minutes of passive recovery in the supine position.
Study NCT05179382 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hydration protocol
Description: I.10 minutes of initial rest in the supine position; II. 90 minutes of treadmill aerobic exercise at an intensity of 60% of the vo2 peak; IV. 60 minutes of passive recovery in the supine position. V. Water ingestion distributed in 10 equal portions, administered at regular intervals of 15 minutes from the 15th minute of exercise until the end of the recovery period.
Study NCT05003466 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 Vaccine (Vero Cells), Inactivated
Description: 2 doses of SARS-CoV-2 Vaccine (Vero Cells), Inactivated with a 28-day interval constitute a primary immunization course. The third dose on 6 months after primary course is the booster dose.~Administer as an intramuscular injection into the lateral deltoid of the upper arm.
Study NCT05003466 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 doses of Placebo should be administered as an intramuscular injection into the lateral deltoid of the upper arm with a 28-day interval.
Study NCT05238766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: DEAL
Description: The DEAL protocol is an Acceptance and Commitment Therapy and Behavioral Activation informed clinical protocol to undermine accommodation and help parents adhere with behavioral treatment plan components.
Study NCT05675787 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate + Atorvastatin
Description: MPA (at a dosage of 250-500 mg/day,) + Atorvastatin (at a dosage of 20 mg/day), by mouth,
Study NCT05646134 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Repetitive Transcranial Magnetic Stimulation
Description: Repetitive transcranial magnetic stimulation (rTMS) is a form of non-invasive brain stimulation therapy that modulates brain excitability.
Study NCT06532786 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fractal Paced
Description: The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks. Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, synchronizing each repetition with fractal external cues presented by a visual metronome. The rest between sets will be set at 2 minutes of rest between sets.
Study NCT06532786 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isochronous Paced
Description: The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks. Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) single in leg extension machine, synchronizing each repetition with isochronus external cues presented by a visual metronome. The rest between sets will be set at 2 minutes of rest between sets.
Study NCT06532786 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self Paced
Description: The intervention consists in a metronome-paced strength training session performed 3 times per week (with 48h of rest between sessions), during 4 weeks. Each session consists in 4 sets of 15 repetitions at 65% of the one-repetition maximal (1RM) in single leg extension machine, at their own self pace (with no metronome). The rest between sets will be set at 2 minutes of rest between sets.
Study NCT05646134 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Magnetic Stimulation
Description: During Sham Transcranial Magnetic Stimulation the coil will be facing the wall making the stimulation inactive
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR3006-1
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3006-1
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR3006-2
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3006-2
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BR3006-3
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT05951946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BR3006-3
Description: All subjects who have been fasting for at least 10 hours prior to administration will take investigational products orally with 150 mL of water at room temperature at around 8 a.m. on the administration day of each period.
Study NCT06378034 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Lactium
Description: 300 mg per day, taken 30 min to 60 min before bedtime
Study NCT06378034 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 300 mg per day, taken 30 min to 60 min before bedtime
Study NCT06376630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Esmolol Hcl 10Mg/Ml Inj
Description: the loading dose of 500 mkg/kg for 1 minute, followed by the initial rate of 50 mkg/kg/min. Individual titration depending on the desired hemodynamical effect (to the heart rate of 60 bpm or to the maximum tolerated dose maintaining stable hemodynamics) every 5-15 minutes (the maximum allowed rate of administration is 300 mkg/kg/min) for 6 hours.~Thereafter patients in both treatment arms - the IV esmolol arm and the placebo arm, will be administered oral β-adrenergic blockers, if decided so by the treating physician and unless contraindicated.
Study NCT04868617 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ATTRACT-I
Description: The aim of this investigation is to evaluate the performance and safety of an ostomy baseplate with a novel skin protection technology and its ability to reduce peristomal skin complications compared to SenSura® Mio. The subject will be randomized to either test product or comparator at enrollment. The subject will wear the test product for approximately 35 days and then cross-over to the comparator (or vice-versa) for approximately 35 days. At each baseplate change, the subject will answer questions about their skin, and take pictures of their stoma and used baseplate. They will also answer quality of life questionnaires at each study visit.
Study NCT04868617 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ATTRACT-I
Description: The aim of this investigation is to evaluate the performance and safety of an ostomy baseplate with a novel skin protection technology and its ability to reduce peristomal skin complications compared to SenSura® Mio. The subject will be randomized to either test product or comparator at enrollment. The subject will wear the test product for approximately 35 days and then cross-over to the comparator (or vice-versa) for approximately 35 days. At each baseplate change, the subject will answer questions about their skin, and take pictures of their stoma and used baseplate. They will also answer quality of life questionnaires at each study visit.
Study NCT06524687 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imvotamab
Description: Administered intravenously
Study NCT05356832 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Pelvic Floor Health Knowledge Quiz
Description: It is a questionnaire to measure the knowledge level of the participants about pelvic floor health.
Study NCT06009367 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fascial Manipulation by Stecco method
Description: Fascial Manipulation (FM) is a method carefully developed by members of the Stecco family after many years of research. FM involves deep kneading of the muscle fascia at specific points called centers of coordination (CC) and centers of fusion (CF) along myofascial sequences, diagonals, and spirals. It has been proposed that the friction caused by manipulation creates localized heat and that, due to the thermosensitive characteristics of fascia, this heat facilitates the transition of hyaluronic acid within the extracellular matrix from a condensed state to a more fluid state, thus restoring the gliding properties of fascia.
Study NCT04537494 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: L. reuteri
Description: Probiotic
Study NCT04537494 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: L. reuteri
Description: Probiotic
Study NCT05599932 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Siremadlin
Description: HDM201 capsule
Study NCT05517187 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: no intervention
Description: Regenerative endodontic treatment induced with blood clot in root canal space as a secondary treatment for failed root canal treated incisors
Study NCT05517187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet rich fibrin
Description: Regenerative endodontic treatment with platelet rich fibrin in root canal space as a secondary treatment for failed root canal treated incisors
Study NCT06396364 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Description: Treatment group: the ankle was immobilized in a walking boot, then a third-generation cryotherapy device (Z- One®, Zamar) was applied daily for 2 hours two times a day up to the day of surgery. The walking boot was removed when the cryotherapy device was applied.
Study NCT06396364 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cryotherapy
Description: Treatment group: the ankle was immobilized in a walking boot, then a third-generation cryotherapy device (Z- One®, Zamar) was applied daily for 2 hours two times a day up to the day of surgery. The walking boot was removed when the cryotherapy device was applied.
Study NCT05087901 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multifocal electroretinogram
Description: A device that records electric potentials generated by the retinal photoreceptors and neural elements in a multifocal fashion
Study NCT04186364 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Assigned Ambassador
Description: If assigned to the intervention group, participants will be assigned a medical student ambassador on arrival to the Emergency Department. A brief discussion may take place to review the child's history and survey results, and a copy of the survey will be placed near the patient's bedside for healthcare personnel to review. The student ambassador will accompany the child and their family through key points of their visit and will be expected to make accommodations for the child as determined by the accommodation survey results. The family will be required to allow the ambassador to stay throughout the ED visit.
Study NCT04836689 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: nasal intermittent positive pressure ventilation (NIPPV).
Description: NIPPV will be administered using Leoni (Heinen\&Löwenstein, Bad Ems, Germany) and RAM cannula (Neotech, Valencia, CA).~After initial setting and before routine blood gas testing, tcCO2 will be connected and calibrated. We will use SenTec digital monitor (SenTec AG, Therwil, Switzerland). Correlation/agreement between the tcCO2 and PCO2 will be assessed and documented in each infant.~For Each infant we will get 2 set of data: Change in measurements when changing from 30 bpm to 10 bpm, and change in measurements when changing from 10 bpm to 30 bpm At the end of each hour, before rate change, we will document the following measurements:TcCO2, FiO2, saturation, the infant's respiratory rate (as measured in the monitor), number of apneas, bradycardia (heart rate\<100 bpm), saturation\<90% and>94% episodes (as measured in the monitor), 1-hour saturation histogram clasification.
Study NCT04700332 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DCFPyL PET/CT
Description: Prostate Membrane Specific Antigen-specific imaging
Study NCT04835077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: Structured aerobic exercises (Each session will consist of 50 minutes and will be divided into three parts: 5 minutes of warm-up exercises, 40 minutes of aerobic exercises, 5 minutes of cool down exercises) will be taught in the first session.
Study NCT04835077 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: postural stabilization exercises
Description: Structured postural stabilization exercises (strengthening exercises, balance-coordination exercises, flexibility exercises) will be taught in the first session.
Study NCT06431477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: telmisartan
Description: QD, PO
Study NCT06431477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Losartan
Description: QD, PO
Study NCT05317845 — intervention group
Intervention type: OTHER
Intervention: No treatment given
Description: The clinical management and prescribed treatment of diabetes and eASCVD/ASCVD risk factors are independent of this study and are part of the routine clinical practice at the discretion of the treating physician.
Study NCT06275139 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Integrated Assessment of Cervicocerebral Vessels
Description: Integrated assessment of cervicocerebral vessels shall be performed, including transcranial color-coded doppler, cerebral perfusion with multislice CT, and cognitive function assessment.
Study NCT06077253 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Iridotomy
Description: Peripheral iridotomy (size >200µm)
Study NCT05606731 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family-Based Childhood Obesity Intervention
Description: The study will focus on the effectiveness of a community- and family-based intervention that will involve multiple family caregivers. The intervention will include in-person and mobile phone components focusing on Latino caregivers of young children, to support evidence-based and age appropriate dietary, media-viewing, and physical activity practices among 2- to 5-year old children.
Study NCT05289115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Experimental group/ Active HD-tDCS
Description: Patients enrolled in this group will received 20 minutes of anodal HD-tDCS ( tDCS 1x1, developed by Soterix Medical Inc.) during 10 sessions. It will be delivered a 3mA intensity electrical current accordingly 10/20 International System on cortical representation zone of left diaphragmatic motor cortex using HD-tDCS.
Study NCT05289115 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Control Group / Sham Group
Description: 10-sessions of anodal HD-tDCS( tDCS 1x1, developed by Soterix Medical Inc.) associated to respiratory training; for 20 minutes (each session) with a 3mA intensity.The device will provide a 30-second ramp-up followed immediately by a 30-second ramp down.
Study NCT05417737 — intervention group
Intervention type: OTHER
Intervention: Ozone therapy
Description: Systemic and/or local ozone administration. Dosage, frequency, and duration of ozone treatment will depend on the treated symptom and clinical evolution. Usually planned 40 sessions.
Study NCT05010096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Copanlisib
Description: Given IV
Study NCT05010096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elimusertib
Description: Given PO
Study NCT04864249 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SNOO
Description: The SNOO is a commercially available device which is a responsive bassinet for neonates. The bassinet is designed to respond to the infant's cries and automatically respond by emitting engineered white noise sounds and providing a rhythmic rocking motion. The infant is also swaddled to remain securely back-down. The SNOO automatically increases the emitted sound and motion if the infant is still crying. However, if the infant does not settle within 3 minutes, the SNOO will shut off and alert the adults for additional assistance. Parents can also modify the SNOO settings to meet the baby's need for sound and/or motion.
Study NCT04864249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe sleep education in the postpartum period
Description: Comprised of education from the postpartum clinical nurse with a corresponding educational handout to take home
Study NCT04864249 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Safe sleep education in the postpartum period
Description: Comprised of education from the postpartum clinical nurse with a corresponding educational handout to take home
Study NCT06002217 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine
Description: Patients in the tap block arm will receive an injection of levobupivacaine 2.5mg/ml
Study NCT06002217 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tap block
Description: Patients in the placebo arm will receive an injection of salin solution 2.5mg/ml , in the same way as tap block
Study NCT05653570 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electrical stimulation
Description: Electrical stimulation will be used to confirm needle and catheter placement within the interfascial plane between the erector spinae muscle and thoracic transverse process.
Study NCT05653570 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: Ultrasound guidance will be used to visualize needle and catheter placement within the interfascial plane between the erector spinae muscle and thoracic transverse process.
Study NCT05653570 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: Ultrasound guidance will be used to visualize needle and catheter placement within the interfascial plane between the erector spinae muscle and thoracic transverse process.
Study NCT05694039 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hearing Aids
Description: The intervention group uses hearing aids, and the intervention group receives hearing aid intervention for 5 years.
Study NCT05255887 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informing Patients With Video
Description: 24-48 hours before the surgery, the patients will be shown an informative video about the intensive care environment in a separate room through a one-on-one interview. (The content of the training to be done with the video is stated in the appendix) In the study, no attempt will be made to the control group patients other than the routine practice of the institution before the surgery. In the study, the day of discharge from the intensive care unit will be counted as the first day, and on the second day, the 'Intensive Care Experience Scale' will be applied to the patients in both the experimental and control groups by face-to-face interview method.
Study NCT05712070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-guided lifestyle modification
Description: Smart watch and smartphone application-based life style modification for 12 weeks
Study NCT05712070 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: A book-based self-education of lifestyle modification
Description: A take-home book-based self-education for lifestyle modification
Study NCT04872192 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: transversus thoracic muscle plane block
Description: transversus thoracic muscle plane block by injection of 15 ml of bupivacaine 0.25% on each side combined with general anaesthesia
Study NCT04872192 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: general anaesthesia
Description: transversus thoracic muscle plane block by injection of 15 ml of saline on each side combined with general anaesthesia
Study NCT05064371 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eptinezumab
Description: Concentrate for solution for IV infusion
Study NCT05125484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: experimental Bowen Technique
Description: Patient was in lying position. Therapist placed thumb on the effected side muscke. Then hooked thumb on lateral edge of muscle to apply pressure against the muscle. Took a pause. Thumb flattened in a medial direction and pluck was created in muscle.~Set of 15-20 bowen moves on upper , middle and lower fibres each with 2 mins gap between each set.~Total treatment time: 20 mins
Study NCT05125484 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Myofacial release technique
Description: Patient was in lying position. MFR applied via ulnar border of both palms while patient being in contralateral side flexion.~20 mins
Study NCT05373446 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SSD8432 300mg
Description: SSD8432 300mg in combination with ritonavir 100mg, day1--day5,BID